Skip to content
Research Article Open access CC BY 4.0

A Comprehensive Review on Biomarker and Its Role in Diseases

Vankodoth Sireesha, Faiqua Fatima, Shafeen Sultana, Mutta Shiva Sai Kumar, Y. Pravarsha, Rama Rao Tatikonda

Cardiology and Angiology: An International Journal · pp. 75–81 · Published 8 Feb 2024

10.9734/ca/2024/v13i1395

Abstract

Biomarkers are essential to clinical practice. Understanding the organized definition, types, and roles of biomarkers in various clinical phases and diseases is crucial for understanding the significance of biomarkers in healthcare and medical research. This data highlights the significance of biomarkers in prognosis prediction, therapeutic decision guidance, and the advancement of personalized medicine, in addition to their role in illness diagnosis. The division of biomarkers into molecular, cellular, and imaging types offers a thorough summary of the various modalities that are employed in biomarker research. In addition, the segmentation according to clinical phases, which differentiates between prognostic, therapeutic, and diagnostic biomarkers, deepens the conversation by emphasizing the diverse functions that biomarkers fulfill in patient treatment. In the diagnosis, prognosis and treatment of a wide range of diseases, biomarkers are a component of a relatively new and perfect clinical instrument. Using biomarkers to research different aspects of diseases, develop new drugs, and track possible therapeutic intervention results has many advantages. They contribute to drug development, personalized medicine, and therapeutic interventions. The aim is to develop biomarkers with higher sensitivity and specificity to enhance decision-making and simplify the drug development process, add depth to the discussion, emphasizing the varied roles of biomarkers in patient care.

Drug development biomarkers pharmaceutical discovery pathogenic processes

References (23)

  1. 1 Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework [DOI]
  2. 2 Glycans and glycoproteins as specific biomarkers for cancer [DOI]
  3. 3 RETRACTED: Biomarkers: Promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases [DOI]
  4. 4 Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values [DOI]
  5. 5 Principles of ecotoxicology [DOI]
  6. 6 Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years [DOI]
  7. 7 Pragmatic issues in biomarker evaluation for targeted therapies in cancer [DOI]
  8. 8 Fit‐for‐Purpose Biometric Monitoring Technologies: Leveraging the Laboratory Biomarker Experience [DOI]
  9. 9 Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers [DOI]
  10. 10 Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis [DOI]
  11. 11 Cystatin C: A Candidate Biomarker for Amyotrophic Lateral Sclerosis [DOI]
  12. 12 Effect of Intensive Blood Pressure Lowering on Kidney Tubule Injury: Findings From the ACCORD Trial Study Participants [DOI]
  13. 13 Mass spectrometry for glycan biomarker discovery [DOI]
  14. 14 Procalcitonin as an Alternative Tumor Marker of Medullary Thyroid Carcinoma [DOI]
  15. 15 Alanine Aminotransferase as a Monitoring Biomarker in Children with Nonalcoholic Fatty Liver Disease: A Secondary Analysis Using TONIC Trial Data [DOI]
  16. 16 K-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis [DOI]
  17. 17 Novel Biomarkers for Cardiovascular Risk Assessment: Current Status and Future Directions [DOI]
  18. 18 Urinary Hepcidin-25 Is Elevated in Patients That Avoid Acute Kidney Injury Following Cardiac Surgery [DOI]
  19. 19 Clinical utility of pleural fluid YKL-40 as a marker of malignant pleural effusion [DOI]
  20. 20 The role of procalcitonin in the follow-up of medullary thyroid cancer [DOI]
  21. 21 Molecular Signatures of Biomarkers in Cancer Development, Diagn osis, and its Prognostic Accuracy [DOI]
  22. 22 The clinical utility of pleural YKL-40 levels in diagnosing pleural effusions. [DOI]
  23. 23 Hepcidin-25 as a Novel Kidney Biomarker for Cardiac Surgery-Associated Acute Kidney Injury [DOI]

Cited by 12

Advancing optical nanosensors with artificial intelligence: A powerful tool to identify disease-specific biomarkers in multi-omics profiling

Bakr Ahmed Taha, Zahraa Mustafa Abdulrahm, Ali J. Addie · Talanta · 2025

Biomarker Isolation and Characterization by Recent Spectroscopic Techniques

Shiva Biswas, Arti Sharma, Neetu Pandey · Advances in Chemical and Materials Engineering · 2025

Molecular biomarkers: their significance and application in pollution monitoring

Darshika Savalia, Isha Dharsandia, Nakul Kumar · Toxicological & Environmental Chemistry · 2025

Interaction between post-tumor inflammation and vascular smooth muscle cell dysfunction in sepsis-induced cardiomyopathy

Rui Liu, Lina Jia, Lin Yu · Frontiers in Immunology · 2025

In Vitro and In Vivo Evaluation Techniques for ACE Inhibitory Peptides: Challenges and Innovations in Predicting Hypertensive Effects

Sonia Bhoria, Jyoti Nuniwaal, Tejpal Dhewa · International Journal of Peptide Research and Therapeutics · 2025

Showing 5 of 12 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

79

Page views

0

PDF downloads

51

Outbound clicks

12

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.